July 9, 2018, 8am ET from Solsys Medical, LLC
NEWPORT NEWS, VIRGINIA, July 9, 2018 – Solsys Medical, LLC (“Solsys”) (formerly known and doing business as Soluble Systems, LLC) (“Soluble Systems”), which markets TheraSkin®, a cellular and tissue-based product for regenerative wound healing, announced today the appointment of Arti Balar Masturzo, M.D as its Chief Medical Officer.
As Chief Medical Officer, Dr. Masturzo will oversee Clinical Strategy, Market Access, Reimbursement, Medical Affairs, Medical Education and will join Solsys’ leadership team that oversees the company’s strategic direction.
“We are very pleased to have Arti join our organization” stated Allan Staley, CEO of Solsys Medical. “Her broad and deep experience in the medical field of wound healing, as a practicing clinician, and her comprehensive business experience will be an asset to our company. Arti’s extensive knowledge in wound management will be invaluable to Solsys Medical as we license and acquire new products and support our flagship product, TheraSkin”
Dr. Masturzo joins Solsys Medical from Healogics, where she led product development and all service related activities as Executive Vice President of Clinical Innovation. Before taking on her role at Healogics, Arti was Corporate Director of Medical Affairs for Accelecare, where she drove company wide clinical education and strategy.
Arti attended the University of South Florida College of Medicine, completed her residency in Internal Medicine at the University of Cincinnati. Additionally, she holds a certification in product development and has authored many clinical publications in the area of wound care.
About Solsys Medical, LLC: Solsys Medical, LLC™ (formerly known and doing business as Soluble Systems, LLC) markets a regenerative medical product under the brand name TheraSkin, designed to help healthcare professionals treat difficult to heal and chronic wounds.
About TheraSkin: TheraSkin is a clinically proven, minimally manipulated, cryopreserved
human skin allograft containing the relevant human biological components needed to treat
difficult to heal and chronic wounds.

For more information on TheraSkin and Solsys Medical, LLC, visit www.solsysmedical.com

Comments are closed.